Cargando…
Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease
BACKGROUND: Non-healing trophic ulcers in Hansen's disease patients is one of the major causes for disability. It has been shown that autologous platelet-rich fibrin matrix (PRFM) is effective in healing chronic non-healing leg ulcers. AIM: The objective of this study is to demonstrate the effi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418979/ https://www.ncbi.nlm.nih.gov/pubmed/28529413 http://dx.doi.org/10.4103/JCAS.JCAS_17_16 |
_version_ | 1783234159259418624 |
---|---|
author | Nagaraju, Umashankar Sundar, Priya K Agarwal, Priyanka Raju, Belliappa P Kumar, Mahesh |
author_facet | Nagaraju, Umashankar Sundar, Priya K Agarwal, Priyanka Raju, Belliappa P Kumar, Mahesh |
author_sort | Nagaraju, Umashankar |
collection | PubMed |
description | BACKGROUND: Non-healing trophic ulcers in Hansen's disease patients is one of the major causes for disability. It has been shown that autologous platelet-rich fibrin matrix (PRFM) is effective in healing chronic non-healing leg ulcers. AIM: The objective of this study is to demonstrate the efficacy of autologous platelet-rich fibrin matrix (PRFM) in non-healing trophic ulcers in patients treated for Hansen's disease. DESIGN: A prospective study. SETTING: An institution-based clinic. PARTICIPANTS: Seven treated patients with Hansen's disease, with a mean age of 38.33 years, with nine non-healing trophic ulcer of more than 6 weeks duration. MEASUREMENTS: Photographs were taken before treatment and at every subsequent sitting. Area and volume were calculated at baseline and every subsequent sitting till the closure was achieved. MATERIALS AND METHODS: The healthy ulcers were treated with PRFM at weekly intervals, repeated once a week for a maximum of five sittings as per requirement. RESULTS: The mean percentage improvement in the area was 93.52%, and volume was 97.74% at the end of the second sitting. All ulcers closed by a maximum of five sittings. No adverse events were noted. CONCLUSION: PRFM for the treatment of trophic ulcers in treated patients with Hansen's disease is a feasible, safe, simple and inexpensive method. |
format | Online Article Text |
id | pubmed-5418979 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-54189792017-05-19 Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease Nagaraju, Umashankar Sundar, Priya K Agarwal, Priyanka Raju, Belliappa P Kumar, Mahesh J Cutan Aesthet Surg Original Article BACKGROUND: Non-healing trophic ulcers in Hansen's disease patients is one of the major causes for disability. It has been shown that autologous platelet-rich fibrin matrix (PRFM) is effective in healing chronic non-healing leg ulcers. AIM: The objective of this study is to demonstrate the efficacy of autologous platelet-rich fibrin matrix (PRFM) in non-healing trophic ulcers in patients treated for Hansen's disease. DESIGN: A prospective study. SETTING: An institution-based clinic. PARTICIPANTS: Seven treated patients with Hansen's disease, with a mean age of 38.33 years, with nine non-healing trophic ulcer of more than 6 weeks duration. MEASUREMENTS: Photographs were taken before treatment and at every subsequent sitting. Area and volume were calculated at baseline and every subsequent sitting till the closure was achieved. MATERIALS AND METHODS: The healthy ulcers were treated with PRFM at weekly intervals, repeated once a week for a maximum of five sittings as per requirement. RESULTS: The mean percentage improvement in the area was 93.52%, and volume was 97.74% at the end of the second sitting. All ulcers closed by a maximum of five sittings. No adverse events were noted. CONCLUSION: PRFM for the treatment of trophic ulcers in treated patients with Hansen's disease is a feasible, safe, simple and inexpensive method. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5418979/ /pubmed/28529413 http://dx.doi.org/10.4103/JCAS.JCAS_17_16 Text en Copyright: © 2017 Journal of Cutaneous and Aesthetic Surgery http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Nagaraju, Umashankar Sundar, Priya K Agarwal, Priyanka Raju, Belliappa P Kumar, Mahesh Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease |
title | Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease |
title_full | Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease |
title_fullStr | Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease |
title_full_unstemmed | Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease |
title_short | Autologous Platelet-rich Fibrin Matrix in Non-healing Trophic Ulcers in Patients with Hansen's Disease |
title_sort | autologous platelet-rich fibrin matrix in non-healing trophic ulcers in patients with hansen's disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5418979/ https://www.ncbi.nlm.nih.gov/pubmed/28529413 http://dx.doi.org/10.4103/JCAS.JCAS_17_16 |
work_keys_str_mv | AT nagarajuumashankar autologousplateletrichfibrinmatrixinnonhealingtrophiculcersinpatientswithhansensdisease AT sundarpriyak autologousplateletrichfibrinmatrixinnonhealingtrophiculcersinpatientswithhansensdisease AT agarwalpriyanka autologousplateletrichfibrinmatrixinnonhealingtrophiculcersinpatientswithhansensdisease AT rajubelliappap autologousplateletrichfibrinmatrixinnonhealingtrophiculcersinpatientswithhansensdisease AT kumarmahesh autologousplateletrichfibrinmatrixinnonhealingtrophiculcersinpatientswithhansensdisease |